AQST stock · CE stock

AQST vs CE · rev $28.3M vs rev $5.09B

Aquestive Therapeutics Inc (AQST) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.

Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.

Celanese Corporation (CE) is a chemicals company listed on US.

Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.

Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.

AQST currently screens at market cap $493.0M. CE currently screens at market cap $5.92B.

Not investment advice. Open the AQST and CE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons